Preexposure Prophylaxis of HIV Infection: the Role of Clinical Practices in Ending the HIV Epidemic (Q48567383)

12 February 2018

title

Preexposure Prophylaxis of HIV Infection: the Role of Clinical Practices in Ending the HIV Epidemic (English)

1 reference

12 February 2018

author name string

Iryna B Zablotska

series ordinal

1 reference

12 February 2018

Catherine C O'Connor

series ordinal

1 reference

12 February 2018

publication date

25 October 2017

1 reference

12 February 2018

published in

Current HIV/AIDS reports

1 reference

12 February 2018

volume

1 reference

12 February 2018

issue

1 reference

12 February 2018

page(s)

201-210

1 reference

12 February 2018

Effectiveness and safety of oral HIV preexposure prophylaxis for all populations

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Global Efforts against HIV Epidemic and HIV Vaccine Development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Beyond the 90-90-90: refocusing HIV prevention as part of the global HIV response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

How do intellectual property law and international trade agreements affect access to antiretroviral therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

HIV providers' likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

A Cross-Sectional Online Survey of HIV Pre-Exposure Prophylaxis Adoption Among Primary Care Physicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Knowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

The impact of patient race on clinical decisions related to prescribing HIV pre-exposure prophylaxis (PrEP): assumptions about sexual risk compensation and implications for access

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Understanding HIV Care Provider Attitudes Regarding Intentions to Prescribe PrEP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Healthcare providers' knowledge of, attitudes to and practice of pre-exposure prophylaxis for HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Are we prepped for preexposure prophylaxis (PrEP)? Provider opinions on the real-world use of PrEP in the United States and Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Knowledge, Beliefs and Practices Regarding Antiretroviral Medications for HIV Prevention: Results from a Survey of Healthcare Providers in New England

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Vital Signs: Increased Medicaid Prescriptions for Preexposure Prophylaxis Against HIV infection--New York, 2012-2015.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Impact of insurance coverage on utilization of pre-exposure prophylaxis for HIV prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Attitude towards antiretroviral Pre-Exposure Prophylaxis (PrEP) prescription among HIV specialists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Healthcare Provider Contact and Pre-exposure Prophylaxis in Baltimore Men Who Have Sex With Men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

PrEP Awareness, Familiarity, Comfort, and Prescribing Experience among US Primary Care Providers and HIV Specialists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Exploratory survey of Florida pharmacists' experience, knowledge, and perception of HIV pre-exposure prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Demographic and HIV-specific characteristics of participants enrolled in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

PrEP Awareness and Attitudes in a National Survey of Primary Care Clinicians in the United States, 2009-2015.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Provider attitudes toward oral preexposure prophylaxis for HIV prevention among high-risk men who have sex with men in Lima, Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Pre-exposure prophylaxis (PrEP) for HIV infection: results of a survey of HIV healthcare providers evaluating their knowledge, attitudes, and prescribing practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Preexposure prophylaxis for HIV infection: healthcare providers' knowledge, perception, and willingness to adopt future implementation in the southern US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Understanding community pharmacist perceptions and knowledge about HIV preexposure prophylaxis (PrEP) therapy in a Mountain West state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Preparing for pre-exposure prophylaxis: perceptions and readiness of Canadian pharmacists for the implementation of HIV pre-exposure prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Putting PrEP into Practice: Lessons Learned from Early-Adopting U.S. Providers' Firsthand Experiences Providing HIV Pre-Exposure Prophylaxis and Associated Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

"Support Your Client at the Space That They're in": HIV Pre-Exposure Prophylaxis (PrEP) Prescribers' Perspectives on PrEP-Related Risk Compensation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Integration of Social, Cultural, and Biomedical Strategies into an Existing Couple-Based Behavioral HIV/STI Prevention Intervention: Voices of Latino Male Couples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Clinician attitudes toward CDC interim pre-exposure prophylaxis (PrEP) guidance and operationalizing PrEP for adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

PrEP in substance abuse treatment: a qualitative study of treatment provider perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Views of policymakers, healthcare workers and NGOs on HIV pre-exposure prophylaxis (PrEP): a multinational qualitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Values and Preferences on the Use of Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Multiple Populations: A Systematic Review of the Literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Engaging healthcare providers to implement HIV pre-exposure prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

The role of healthcare providers in the roll out of preexposure prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Combining biomedical preventions for HIV: Vaccines with pre-exposure prophylaxis, microbicides or other HIV preventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Pharmacists as providers of HIV pre-exposure prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

The European preexposure prophylaxis revolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Preexposure Prophylaxis (PrEP) for HIV Prevention: The Primary Care Perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

The preexposure prophylaxis revolution: from clinical trials to routine practice: implementation view from the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Role of medication therapy management in preexposure prophylaxis therapy for HIV prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Integrating Antiretroviral Strategies for Human Immunodeficiency Virus Prevention: Post- and Pre-Exposure Prophylaxis and Early Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Towards an integrated primary and secondary HIV prevention continuum for the United States: a cyclical process model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Applying a PrEP Continuum of Care for Men Who Have Sex With Men in Atlanta, Georgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

From modeling to morals: imagining the future of HIV PREP in Lesotho

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Executive summary: Pre-exposure prophylaxis for prevention of HIV infection in adults in Spain: July 2016.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Help end the HIV epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

The Impact of Preexposure Prophylaxis Among Men Who Have Sex With Men: An Individual-Based Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Evaluating the impact of prioritization of antiretroviral pre-exposure prophylaxis in New York

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Limited Awareness and Low Immediate Uptake of Pre-Exposure Prophylaxis among Men Who Have Sex with Men Using an Internet Social Networking Site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

NHS England should reconsider PrEP decision.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

What do we know about the cost-effectiveness of HIV preexposure prophylaxis, and is it affordable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-017-0367-7

Prevalence and predictors of unmet need for supportive services among HIV-infected persons: impact of case management

21 January 2018

1 reference

12 December 2020

Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men.

1 reference

12 December 2020

Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention

1 reference

12 December 2020

Knowledge of and opinions on HIV preexposure prophylaxis among front-line service providers at Canadian AIDS service organizations

1 reference

12 December 2020

Role of the pharmacist in pre-exposure chemoprophylaxis (PrEP) therapy for HIV prevention.

1 reference

12 December 2020

The promises and challenges of pre-exposure prophylaxis as part of the emerging paradigm of combination HIV prevention

1 reference

12 December 2020

Translating PrEP effectiveness into public health impact: key considerations for decision-makers on cost-effectiveness, price, regulatory issues, distributive justice and advocacy for access

1 reference

12 December 2020

Preexposure Prophylaxis For HIV Prevention: What We Know and What We Still Need to Know for Implementation

1 reference

12 December 2020

Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015

1 reference

12 December 2020

UK PrEP decision re-ignites HIV activism

1 reference

12 December 2020

Pre-exposure prophylaxis for the prevention of HIV infection: a new prevention paradigm?

1 reference

12 December 2020

Perceptions about HIV pre-exposure prophylaxis among healthcare professionals in Spain (PERPPRES Study).

1 reference

12 December 2020

Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa

1 reference

12 December 2020

Towards a fair consideration of PrEP as part of combination HIV prevention in Latin America

1 reference

12 December 2020

PrEP implementation in the Asia-Pacific region: opportunities, implementation and barriers

1 reference

12 December 2020

Where next with preexposure prophylaxis?

1 reference

12 December 2020

Likely impact of pre-exposure prophylaxis on HIV epidemics among men who have sex with men.

1 reference

12 December 2020

Highlights from the 24th Conference on Retroviruses and Opportunistic Infections: 13-16 February 2017, Seattle, Washington, USA.

1 reference

12 December 2020

10.1007/S11904-017-0367-7

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018